Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.
Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions detected. The page content appears unchanged with the same study details and status across screenshots.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublication section wording changed to say that publications are automatically filled from PubMed, and the revision tag updated to v3.3.2.SummaryDifference0.0%
- Check27 days agoChange DetectedThe page no longer displays the government funding lapse notice describing potential delays and operation status; this was an administrative banner rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check35 days agoChange DetectedThe study page now shows a Terminated status, indicating the IMPAHCT trial is no longer recruiting.SummaryDifference0.0%
- Check42 days agoChange DetectedSeveral external health information links were removed from the ClinicalTrials.gov record, including MedlinePlus Genetics, GARD, PubMed entries, and government resource pages. These deletions remove quick access to background information and official resources but do not alter the study's reported design, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check70 days agoChange DetectedMajor update: adds a government funding/operating status notice and marks a new version (v3.2.0) replacing v3.1.0.SummaryDifference3%
Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.